CA Rudramurthy BV at Vachana Investments is of the view that Shilpa Medicare is an attractive buy and feels that the stock may double in 2-3 years.
first published: Jul 24, 2015 03:00 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

